RATIONALE: Mast cells (MCs) are well-known for their role in allergic responses. They can be activated through cross-linking of their high affinity IgE receptors (FcεRI) by allergen, leading to the release of many proinflammatory mediators. Sialic acid-binding immunoglobulin-like (Siglec)-8 is a CD33-related receptor expressed on human MCs, though not yet described on skin MCs. A key feature of Siglec-8 is its inhibitory (ITIM) motif located within the cytoplasmic domain, suggesting that it may inhibit activating (ITAM) signaling. We hypothesized that Siglec-8 would be expressed on human skin MCs and that its engagement would prevent MC degranulation induced by some secretagogues but not others. METHODS: Primary MCs were obtained by enzymatic dispersion of discarded human skin. MC were assessed for purity and evaluated for Siglec-8 expression using flow cytometry. Once MCs achieved greater than 95% purity, around 4 weeks post-isolation, the function of Siglec-8 was evaluated. MCs were stimulated with various concentrations of anti-FcεRI in the presence or absence of mouse anti-Siglec-8 (1 mg/ml) and degranulation was assessed via colorimetric assay of beta-hexosaminidase. Siglec-8 inhibitory effects were also evaluated following stimulation with complement factor 5a (C5a) or compound 48/80 which signal through C5aR and MrgX2, respectively, on MCs. RESULTS: All human skin MCs expressed Siglec-8 on their cell surface throughout the culture period. Siglec-8 engagement inhibited beta-hexosaminidase release triggered via FcεRI, but not via C5aR or MrgX2. CONCLUSIONS: Siglec-8 engagement inhibits ITAM, but not sevenspanner receptor-mediated MC activation in vitro. Laboratory of Allergic Diseases/ NIAID/NIH, Bethesda, MD. RATIONALE: IL-3 may be used to culture mast cells (MCs) from mouse marrow. MCs cultured from human peripheral blood mononuclear cells (PBMC), in contrast, require stem cell factor (SCF). IL-3 may be used to enhance MC outgrowth in these cultures. We ask what differences the addition of IL-3 would have over the time in SCF-dependent cultures. METHODS: PBMCs from lymphocytapheresis were cultured in SCF over 6-8 weeks +/-IL-3. Expression of cell surface markers and intracellular tryptase was determined throughout the culture using flow cytometry. b-hexosaminidase release was used to assess IgE-dependent MC degranulation. RESULTS: A transient basophil-like cell population (FcepsilonRI+, CD117-) was observed in cultures containing IL-3. Sorted cells from a 3-week IL-3 MC culture were cultured for 4 additional weeks in SCF. The FcepsilonRI+, CD117-(basophil-like cells) and FcepsilonRI-, CD117-cells did not survive culture. FcepsilonRI+, CD117+ and FcepsilonRI-, CD117+ cells remained viable and developed into MCs. Tryptase was detectable only in CD117+ cells. MCs at 6-8 weeks in cultures containing IL-3 exhibited less tryptase and a lower rate of b-hexosaminidase release. CONCLUSIONS: IL-3 induces a transient basophil-like cell population which is absent by 6 weeks. MCs cultured in IL-3 contained less tryptase and exhibited lower degranulation than MCs cultured in the absence of IL-3. Thus, the presence or absence of IL-3 during the culture of MCs from PBMC must be considered when reporting outcomes. Whether these findings are relevant to the understanding of human MC populations in vivo remains to be determined.
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Dermal Exposure to Antimicrobial Chemicals Induce Mast Cell Augmentation and Mitochondrial Modification Lisa M. Weatherly, PhD, Hillary L. Shane, PhD, Ewa Lukomska, Rachel Baur, and Stacey Anderson, PhD; CDC/NIOSH, Morgantown, WV. RATIONALE: Exposure to occupational chemicals can lead to allergic disease such as asthma and allergic contact dermatitis. The skin plays a major role in the development of allergy. Mast cells are in high abundance in the skin where they interact with the environment and are known for their roles in both innate and adaptive immune reactions. However, specific roles for mast cells in chemical induced allergic disease have not been well characterized. We hypothesize that dermal chemical exposure may alter immune response via effects on mast cells. METHODS: BALB/c mice were dermally exposed to representative antimicrobial chemicals. Chemicals were selected based on hypersensitivity classification. After 6 or 24 hours following final exposure, mast cell markers and mitochondrial reactive oxygen species (mROS) were assessed by flow cytometry and caspase-1 activity was measured via Caspase-Glow 1 Inflammasome Assay in the draining lymph-node (dLN) and/or skin. RESULTS: Mast cells in animals exposed to the adjuvant (triclosan) increased in number and frequency in the skin 6 hour post single exposure, however by 24 hours numbers were back down to baseline levels. Triclosan exposure also resulted in mROS level alterations and increases in caspase-1 activity in dLN cells. Interestingly, 24 hours post exposure, mast cell frequency in the skin increased in animals exposed to the T-cell mediated sensitizer (didecyldimethlyammonium chloride) but decreased in animals exposed to the IgE mediated sensitizer (ortho-phthalaldehyde). CONCLUSIONS: These findings demonstrate an early involvement for mast cells in chemical induced allergic disease and suggest the potential for divergent roles in hypersensitivity responses.
